Cara Therapeutics, Inc. (CARA) Financial Statements (2024 and earlier)

Company Profile

Business Address 4 STAMFORD PLAZA
STAMFORD, CT 06902
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:156,749236,789251,490218,165182,77992,569
Cash and cash equivalents63,74113,45331,68318,30515,0819,388
Short-term investments  153,582149,242136,701146,30283,181
Other undisclosed cash, cash equivalents, and short-term investments93,00869,75470,56563,15921,396 
Restricted cash and investments408   361 
Receivables4,4531,1522,0641,7871,590731
Inventory, net of allowances, customer advances and progress billings2,3832,584    
Inventory2,3832,584    
Prepaid expense16,2672,51912,0768,8634,8051,635
Other undisclosed current assets(11,350)(69,754)(70,565)(63,159)(21,396)123
Total current assets:168,910173,290195,065165,656168,13995,058
Noncurrent Assets
Operating lease, right-of-use asset1,5512,9734,2793,036
Property, plant and equipment4266318407008801,177
Long-term investments and receivables  69,75470,56563,15921,396 
Long-term investments  69,75470,56563,15921,396 
Restricted cash and investments 408408408408769
Other undisclosed noncurrent assets11,350     
Total noncurrent assets:13,32773,76676,09267,30322,6841,946
TOTAL ASSETS:182,237247,056271,157232,959190,82397,004
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:21,54015,86116,88119,66513,6228,506
Employee-related liabilities4,9594,9553,2932,3701,864
Accounts payable9,6045,6254,8939,1004,3713,829
Accrued liabilities6,736629839635802457
Other undisclosed accounts payable and accrued liabilities5,2004,6486,1946,6376,0792,356
Deferred revenue    22,262
Debt    967  
Contract with customer, liability26,825
Other undisclosed current liabilities1,9181,7551,602   
Total current liabilities:23,45817,61618,48342,89440,4478,506
Noncurrent Liabilities
Long-term debt and lease obligation:  1,9183,6733,352  
Liabilities, other than long-term debt    16,7461,718
Deferred revenue and credits1,718
Contract with customer, liability15,184
Deferred rent credit     1,562
Operating lease, liability 1,9183,6733,352
Total noncurrent liabilities: 3,8367,3463,35216,7461,718
Total liabilities:23,45821,45225,82946,24657,19310,224
Equity
Equity, attributable to parent158,779227,522249,001186,713133,63086,780
Common stock535350473933
Additional paid in capital726,630708,585641,195587,223428,059307,158
Accumulated other comprehensive income (loss)(1,672)(358)73170(114)(70)
Accumulated deficit(566,232)(480,758)(392,317)(400,727)(294,354)(220,341)
Total equity:158,779227,522249,001186,713133,63086,780
Other undisclosed liabilities and equity  (1,918)(3,673)   
TOTAL LIABILITIES AND EQUITY:182,237247,056271,157232,959190,82397,004

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues41,86723,028135,08219,88613,469911
Cost of revenue
(Cost of Goods and Services Sold)
 (34)     
Other undisclosed gross profit      
Gross profit:41,83323,028135,08219,88613,469911
Operating expenses(129,402)(112,111)(129,697)(131,565)(90,851)(60,396)
Other undisclosed operating income34     
Operating income (loss):(87,535)(89,083)5,385(111,679)(77,382)(59,485)
Nonoperating income
(Other Nonoperating income)
2,0616422,3344,4902,9801,156
Income (loss) from continuing operations before income taxes:(85,474)(88,441)7,719(107,189)(74,402)(58,329)
Income tax benefit   691816389204
Income (loss) from continuing operations:(85,474)(88,441)8,410(106,373)(74,013)(58,125)
Income (loss) before gain (loss) on sale of properties:(88,441)8,410(106,373)(74,013)(58,125)
Net income (loss) available to common stockholders, diluted:(85,474)(88,441)8,410(106,373)(74,013)(58,125)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(85,474)(88,441)8,410(106,373)(74,013)(58,125)
Other comprehensive income (loss)(1,314)(431)(97)284(44)(73)
Other undisclosed comprehensive loss      
Comprehensive income (loss):(86,788)(88,872)8,313(106,089)(74,057)(58,198)
Other undisclosed comprehensive income, net of tax, attributable to parent      
Comprehensive income (loss), net of tax, attributable to parent:(86,788)(88,872)8,313(106,089)(74,057)(58,198)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: